Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2022 Mar 22;115(2):549–550. doi: 10.1016/j.athoracsur.2022.02.066

ECMO and CRRT “All in One!” in COVID-19 Era

Ignazio Condello 1, Giulio Pavan 2
PMCID: PMC8937607  PMID: 35331709

To the Editor:

Extracorporeal membrane oxygenation (ECMO) is used in critically ill patients presenting acute cardiac and/or pulmonary dysfunctions, who are at high risk of developing acute kidney injury and fluid overload. Continuous renal replacement therapy (CRRT) is commonly used in intensive care units to provide renal replacement and fluid management. Renal replacement therapy (RRT) consists of a broad range of techniques. A distinction can be made based on membrane permeability, method of molecular clearance (diffusion or convection or a combination of both), and the duration of treatment and equipment used.1 When utilizing ECMO as a bridge to recovery of the lungs, ECMO provides pulmonary support, during which time lung recovery is dependent upon regenerative functions and may occur in a setting of minimally traumatic mechanical ventilation or even in the absence of mechanical ventilation. We read with great interest the article by Hall and associates.2 The authors reviewed 505 patients with confirmed COVID-19 supported with ECMO at 45 hospitals and estimated risk factors for mortality—they concluded that ECMO facilitates salvage and survival of select critically ill patients with COVID-19.2 International registries tracking ECMO in COVID-19 patients reveal a 21%-70% incidence of acute renal injury requiring RRT during ECMO support. The indications for initiating RRT in patients on ECMO are similar to those for patients not requiring ECMO. RRT can be administered during ECMO via a temporary dialysis catheter, placement of a circuit in-line hemofilter, or direct connection of continuous RRT in-line with the ECMO circuit.1 We propose a conceptual device scheme that allows for managing the CRRT and ECMO in an integrated way, dialoguing avoiding the insertion of additional introducers on the patient for CRRT. Today there are no integrated software systems for these 2 technologies, we think it could be interesting to develop them in the near future through the use of smart pumps integrated with ECMO devices (Figure 1 ).

Figure 1.

Figure 1

Sketch for smart pumps dialogue and control between extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) systems.

References

  • 1.Roberts S.H., Goodwin M.L., Bobba C.M., et al. Continuous renal replacement therapy and extracorporeal membrane oxygenation: implications in the COVID-19 era. Perfusion. Published online September 8, 2021. [DOI] [PubMed]
  • 2.Hall C.A., Jacobs J.P., Stammers A.H., et al. Multi-institutional analysis of 505 patients with coronavirus disease-2019 supported with extracorporeal membrane oxygenation: predictors of survival. Ann Thorac Surg. 2022;114:61–68. doi: 10.1016/j.athoracsur.2022.01.043. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Annals of Thoracic Surgery are provided here courtesy of Elsevier

RESOURCES